HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structure of beta-glucan oligomer from laminarin and its effect on human monocytes to inhibit the proliferation of U937 cells.

Abstract
We analyzed the human monocyte-stimulating ability of laminarin from Eisenia bicyclis, lichenan from Cetraria islandica, and their oligomers depolymerized with endo-1,3-beta-glucanase from Arthrobacter sp. The respective beta-glucan oligomers with different degrees of polymerization (DP) were fractionated from hydrolytic products of laminarin and lichenan using gel-filtration chromatography. The monocyte-conditioned medium pre-cultured in the presence of a fraction of beta-glucan oligomer (DP>/=8) from laminarin exhibited inhibitory activity against the proliferation of human myeloid leukemia U937 cells, while those pre-cultured with other beta-glucan oligomers and the original laminarin and lichenan showed little or no activity. NMR analysis indicated that the beta-glucan oligomer (DP>/=8) has an average DP value of 13, and its ratio of beta-1,3- to beta-1,6-linkages in glucopyranose units was estimated to be 1.3:1. These results indicate that the beta-1,3-glucan oligomer with a higher content of beta-1,6-linkage stimulates monocytes to inhibit the proliferation of U937 cells.
AuthorsZhongcun Pang, Kodo Otaka, Takashi Maoka, Kumi Hidaka, Sumio Ishijima, Masayuki Oda, Masatake Ohnishi
JournalBioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem) Vol. 69 Issue 3 Pg. 553-8 (Mar 2005) ISSN: 0916-8451 [Print] England
PMID15784984 (Publication Type: Journal Article)
Chemical References
  • Biopolymers
  • Glucans
  • Polysaccharides
  • beta-Glucans
  • laminaran
Topics
  • Biopolymers (chemistry, pharmacology)
  • Cell Division (drug effects)
  • Glucans
  • Humans
  • Molecular Structure
  • Monocytes (cytology, drug effects)
  • Nuclear Magnetic Resonance, Biomolecular
  • Polysaccharides (chemistry)
  • U937 Cells
  • beta-Glucans (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: